At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
03696 INSILICO
Not Yet Opened 02-12 16:08:08
73.650
+0.450
+0.61%
High78.100Low71.500Vol1.50M
Open74.500D1 Closing73.200Amplitude9.02%
Mkt Cap42.10BTradable Cap42.10BTotal Shares571.62M
T/O111.36MT/O Rate0.26%Tradable Shares571.62M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.
BUZZ-InSilico hits fresh high on partnership deal with China Medical
Reuters  ·  02-10 10:17
BUZZ-InSilico hits fresh high on partnership deal with China Medical
Insilico Medicine Enters Drug Development Partnership With China Medical System
MT Newswires Live  ·  02-10 09:38
Insilico Medicine Enters Drug Development Partnership With China Medical System
InSilico Medicine (3696.HK) and CMS (867.HK) Announce AI-Focused Drug Development Partnership
Bulletin Express  ·  02-10 08:21
InSilico Medicine (3696.HK) and CMS (867.HK) Announce AI-Focused Drug Development Partnership
Insilico Partners with CMS on Multi-Million-Dollar AI-Driven Drug Development for CNS and Autoimmune Disorders
Stock News  ·  02-10 08:20
Insilico Partners with CMS on Multi-Million-Dollar AI-Driven Drug Development for CNS and Autoimmune Disorders
Insilico Medicine Cayman Topco startet Milliarden-Kooperation mit CMS zur Entwicklung von Medikamenten für das zentrale Nervensystem und Autoimmunerkrankungen
Reuters  ·  02-10 08:01
Insilico Medicine Cayman Topco startet Milliarden-Kooperation mit CMS zur Entwicklung von Medikamenten für das zentrale Nervensystem und Autoimmunerkrankungen
Insilico Medicine Cayman Topco - Deal to Collaborate Across Multiple Projects in Fields of Central Nervous System, Autoimmune Diseases
THOMSON REUTERS  ·  02-10 08:00
Insilico Medicine Cayman Topco - Deal to Collaborate Across Multiple Projects in Fields of Central Nervous System, Autoimmune Diseases
Insilico Medicine Cayman Topco - Also Expected to Receive R+D Funding Support of up to Several Tens of Millions of HKD for Each Program
THOMSON REUTERS  ·  02-10 08:00
Insilico Medicine Cayman Topco - Also Expected to Receive R+D Funding Support of up to Several Tens of Millions of HKD for Each Program
Insilico Medicine Cayman Topco - Insilico Medicine and CMS Enter Into Drug Development Collaboration
THOMSON REUTERS  ·  02-10 08:00
Insilico Medicine Cayman Topco - Insilico Medicine and CMS Enter Into Drug Development Collaboration
Insilico Medicine ernennt Halle Zhang zur Vizepräsidentin für klinische Entwicklung in der Onkologie
Reuters  ·  02-06
Insilico Medicine ernennt Halle Zhang zur Vizepräsidentin für klinische Entwicklung in der Onkologie
Insilico Medicine Appoints Halle Zhang, Phd (Med), as Vice President, Clinical Development - Oncology
THOMSON REUTERS  ·  02-06
Insilico Medicine Appoints Halle Zhang, Phd (Med), as Vice President, Clinical Development - Oncology
Insilico Medicine nominiert ISM5059 als neuen NLRP3-Hemmer für Entzündungstherapien
Reuters  ·  02-05
Insilico Medicine nominiert ISM5059 als neuen NLRP3-Hemmer für Entzündungstherapien
Insilico Medicine Nominates ISM5059, the Peripheral-Restricted Nlrp3 Inhibitor as Preclinical Candidate, for the Treatment of Multiple Inflammatory and Metabolism Indications
THOMSON REUTERS  ·  02-05
Insilico Medicine Nominates ISM5059, the Peripheral-Restricted Nlrp3 Inhibitor as Preclinical Candidate, for the Treatment of Multiple Inflammatory and Metabolism Indications
InSilico Medicine Cayman TopCo (03696) Announces Monthly Return for January 2026
Bulletin Express  ·  02-05
InSilico Medicine Cayman TopCo (03696) Announces Monthly Return for January 2026
Insilico Medicine Receives USD 5Million Milestone Payment From Menarini Group Following First-in-Human (Fih) Achievement for Men2501
THOMSON REUTERS  ·  02-03
Insilico Medicine Receives USD 5Million Milestone Payment From Menarini Group Following First-in-Human (Fih) Achievement for Men2501
Southwest Securities Initiates Coverage on INSILICO (03696) with Positive Outlook, Anticipates Innovation Delivery
Stock News  ·  02-03
Southwest Securities Initiates Coverage on INSILICO (03696) with Positive Outlook, Anticipates Innovation Delivery
Insilico Medicine Advances AI Drug Discovery Model With New Partnerships
Simply Wall St.  ·  02-03
Insilico Medicine Advances AI Drug Discovery Model With New Partnerships
BUZZ-Insilico hits fresh high on milestone payment from Menarini Group
Reuters  ·  02-03
BUZZ-Insilico hits fresh high on milestone payment from Menarini Group
INSILICO (03696) Receives HK$39 Million Milestone Payment from Menarini as Collaborative Project MEN2501 Administers First Dose to Patient
Stock News  ·  02-03
INSILICO (03696) Receives HK$39 Million Milestone Payment from Menarini as Collaborative Project MEN2501 Administers First Dose to Patient
Insilico Medicine erhält Meilensteinzahlung von Menarini nach Beginn der Phase-I-Studie mit MEN2501
Reuters  ·  02-03
Insilico Medicine erhält Meilensteinzahlung von Menarini nach Beginn der Phase-I-Studie mit MEN2501
Insilico Medicine Rides ISM8969 Deals And AI Platform To Strong Rally
Simply Wall St.  ·  02-02
Insilico Medicine Rides ISM8969 Deals And AI Platform To Strong Rally

Introduction

Company Name.
INSILICO
Affiliated Markets:
SEHK
Listing Date:
--
Main Business:
InSilico Medicine Cayman TopCo is a company principally engaged in the research and development of artificial intelligence in pharmaceuticals. The Company is engaged in the research and development of drug discovery engines. In addition, the Company is engaged in the copabdrug discovery and development of disease target identification, generation of novel molecules data, and predicting clinical trial outcomes.
Issue price:
--